Latest Gene expression profiling Stories
febit Technology Enables the Conversion of New Sequence Data into Biochips for Gene Expression Profiling and Sequence Capture for Next-Generation Sequencing Within Days LEXINGTON, Mass. and HEIDELBERG, Germany, June 29 /PRNewswire/ -- febit holding gmbh announced today the launch of the first biochip on the market covering the newly published whole mouse genome. The biochip from febit enables up-to-date profiling and enrichment of genes and SNPs of interest using Gene Expression Profiling,...
-Knowledge May Improve Diagnosis for Children with Cornelia deLange Syndrome- PHILADELPHIA, May 27 /PRNewswire-USNewswire/ -- An international team of scientists studying a rare genetic disease discovered that a bundle of proteins with the long-established function of keeping chromosomes together also plays an important role in regulating genes in humans. When gene regulation is disrupted in the multisystem genetic disease Cornelia deLange syndrome (CdLS), children may suffer missing...
A study of gene expression in chickens, frogs, pufferfish, mice and people has revealed surprising similarities in several key tissues. Researchers writing in BioMed Central's open access Journal of Biology have shown that expression in tissues with a limited number of specialized cell types is strongly conserved, even between the mammalian and non-mammalian vertebrates.Timothy Hughes from the University of Toronto, Canada, worked with a team of researchers to investigate evolutionary...
A novel technique for carrying out gene-expression profiling is set to challenge the market dominance of the current, widely used methodology, reports Genetic Engineering & Biotechnology News (GEN). Some scientists believe that digital gene-expression profiling, a fully quantitative approach for gene-expression analysis, will eventually rival microarrays in this application area, according to the April 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2844)."Digital...
Scientists discovered a new way to more accurately predict the spread of breast cancer to other tissues in the body by examining gene subnetworks.The discovery was made by a team of U.S. and South Korean researchers who identified the subnetworks by using bioinformatics algorithms -- an information technology approach to solving molecular biology problems.The scientists sifted through mountains of gene expression profiles from large groups of women with breast cancer. The data included women...
Expression Analysis, Inc., the industry's leading provider of genomic services for clinical trials and research, has adopted the Cure Kids Cancer Coalition as its charity and will begin its fund-raising efforts next month. The announcement was made by Karen Michailo, Director of Marketing for Expression Analysis. "Cure Kids Cancer is a worthy cause, and we at Expression Analysis feel this is the perfect opportunity for us to help in the fight against pediatric cancer," Michailo said. "Of...
Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests. Early-onset diabetes, also known as type-1 diabetes, is an autoimmune disease, caused when the immune system attacks and destroys insulin-producing cells in a person's pancreas. What triggers that immune response apparently has less to do with having a distinct...
OSLO, October 28 /PRNewswire-FirstCall/ -- DiaGenic ASA (OSL:DIAG) today announced that it has signed a service provider agreement with DNAVision, a leading panEuropean provider of gene expression-based diagnostic testing and services With this laboratory service and following CE marking scheduled in early2009, DiaGenic will be able to offer healthcare providers and patients in Europe its innovative blood-based gene-expression diagnostic test for early detection of breast cancer and...
Integrated Media Holdings, Inc. (OTCBB: IMHI) announced today that its wholly owned subsidiary, TeleChem International, Inc. doing business as Arrayit Company, has entered into an exclusive agreement with BioSystems International SAS for the supply and license rights to produce state-of-the-art microarrays featuring antibodies that identify proteins uniquely expressed in human plasma. The Human Plasma Proteome Microarray may lead to exciting new clinical applications in human disease...
Gene Express, Inc. today announced that it has signed a definitive agreement with AbaStar MDx Inc. to license Gene Express, Inc.'s SEM Center and StaRT-PCR Technology. AbaStar MDx will utilize Gene Express' proprietary technology in the development and commercialization of genetic biomarkers for the accurate diagnoses of neurological and psychological disorders. Current methods for diagnosing neurodegenerative and psychological disorders predominantly involve physician observations and...
